1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Macular Edema Global Clinical Trials Review, H2, 2015

Macular Edema Global Clinical Trials Review, H2, 2015

  • July 2015
  • -
  • Global Data
  • -
  • 129 pages

Macular Edema Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Macular Edema Global Clinical Trials Review, H2, 2015" provides an overview of Macular Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Macular Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Macular Edema Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Macular Edema 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Macular Edema to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Macular Edema to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Macular Edema 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Macular Edema Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Macular Edema 33
Jun 16, 2015: Clearside Biomedical Announces Favorable End-of-Phase 2 Review with the FDA 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Allergan Plc 34
Clinical Trial Overview of Allergan Plc 34
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
F. Hoffmann-La Roche Ltd. 39
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39
Regeneron Pharmaceuticals, Inc. 41
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 41
Bayer AG 42
Clinical Trial Overview of Bayer AG 42
Asociacion para Evitar la Ceguera en Mexico I.A.P. 43
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Merck and Co., Inc. 45
Clinical Trial Overview of Merck and Co., Inc. 45
Eyetech Pharmaceuticals, Inc. 46
Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 46
Clearside BioMedical, Inc. 47
Clinical Trial Overview of Clearside BioMedical, Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
National Eye Institute 48
Clinical Trial Overview of National Eye Institute 48
The Johns Hopkins University 49
Clinical Trial Overview of The Johns Hopkins University 49
Queen's University 50
Clinical Trial Overview of Queen's University 50
Shahid Beheshti University of Medical Sciences 51
Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 51
Assistance Publique - Hopitaux de Paris 52
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 52
Department of Health, UK 53
Clinical Trial Overview of Department of Health, UK 53
Duke University 54
Clinical Trial Overview of Duke University 54
Hallym University Medical Center 55
Clinical Trial Overview of Hallym University Medical Center 55
Hong Kong Eye Hospital 56
Clinical Trial Overview of Hong Kong Eye Hospital 56
Johann Wolfgang Goethe University Hospitals 57
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 57
Five Key Clinical Profiles 58
Appendix 126
Abbreviations 126
Definitions 126
Research Methodology 127
Secondary Research 127
About GlobalData 128
Contact Us 128
Disclaimer 128
Source 129

List of Tables
Macular Edema Therapeutics, Global, Clinical Trials by Region, 2015* 7
Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Macular Edema Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Macular Edema Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Macular Edema to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Macular Edema to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Macular Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Macular Edema Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Macular Edema Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Macular Edema Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Macular Edema Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 34
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 39
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 41
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 42
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2015* 43
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 44
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 45
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2015* 46
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Clearside BioMedical, Inc., 2015* 47
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 48
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015* 49
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2015* 50
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 51
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 52
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 53
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 54
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Hallym University Medical Center, 2015* 55
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Eye Hospital, 2015* 56
Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2015* 57

List of Figures
Macular Edema Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Macular Edema Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Macular Edema Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Macular Edema to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Macular Edema to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Macular Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Macular Edema Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Macular Edema Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 127

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.